BEAM - CIK 0001745999
Beam Therapeutics Inc. (BEAM) reported revenue of $139.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $139.74M | +120.0% |
| FY 2024 | $63.52M | -83.2% |
| FY 2023 | $377.71M | +520.0% |
| FY 2022 | $60.92M | +17.5% |
| FY 2021 | $51.84M | +215916.7% |
| FY 2020 | $24.00K | +33.3% |
| FY 2019 | $18.00K | - |
Beam Therapeutics Inc. (BEAM) reported revenue of $139.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Beam Therapeutics Inc.'s revenue grew from $18.00K to $139.74M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.